ArticleMarine biotechnology (New York, N.Y.)2026
Functional Characterization of a Novel FADD from Anodonta woodiana Reveals Its Regulatory Roles in Apoptotic Cascades and Antibacterial Immunity.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Fas-associated death domain (FADD) is a core conserved adaptor in death receptor-induced apoptotic signaling pathway that plays a crucial role in apoptosis and innate immunity in vertebrates. However, the function of FADDs in invertebrates, especially in bivalve mollusks, remains elusive. In the present study, a novel molluscan FADD homolog (AwFADD) was identified and functionally characterized from the bivalve Anodonta woodiana. The AwFADD protein consists of 232 amino acids and harbors two conserved functional domains: an N-terminal death effector domain (DED) and a C-terminal death domain (DD). Tissue expression profiling revealed that AwFADD was ubiquitously expressed in all examined tissues, with predominant expression in the hepatopancreas and hemocytes. Upon challenge with Aeromonas hydrophila or lipopolysaccharide, AwFADD mRNA expression was upregulated in hemocytes of A. woodiana, implying its potential involvement in host antibacterial responses. RNA interference‑mediated knockdown of AwFADD suppressed the expression of AwCaspase-8/-3, whereas it enhanced transcripts of MyD88-dependent pathway genes and downstream immune-related effectors in hemocytes in response to A. hydrophila infection. Subcellular localization analysis suggested that AwFADD was predominantly localized in the cytoplasm of HEK293T cells. Dual-luciferase reporter assays further indicated that AwFADD overexpression enhanced the activation of NF-κB and AP-1 in a dose-dependent manner under basal conditions, but suppressed MyD88-triggered NF-κB/AP-1 signaling activation. These findings suggest that AwFADD may serve as a crucial bifunctional regulator that integrates apoptotic cascade activation and MyD88-dependent antibacterial immune responses in A. woodiana.
Indexed as
Identifiers
42905182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.